Morgan Stanley
-
-
-
-
-
-
-
Bristol Myers Squibb Strengthens and Diversifies Oncology Portfolio With Acquisition of Mirati Therapeutics
-
-
-
-
-
-
-
Bristol Myers Squibb to Participate in the Morgan Stanley 20th Annual Global Healthcare Conference
-
-
-
-
-
-
-
Bristol-Myers Squibb Co. (BMY) Raises Project Pipeline Revenue Guidance at Analyst Day - Morgan Stanley
-
-
-
-
-
-
-
Bristol Myers Squibb Announces Accepted Amounts and Pricing Terms of Tender Offers for an Aggregate Purchase Price of Up to $4.0 Billion
-
-
-
-
-
-
-
Choppy markets leave U.S. bank bonus decisions in limbo
-
-
-
-
-
-
-
Bristol-Myers Squibb to Take Part at the Morgan Stanley Conference
-
-
-
-
-
-
-
Bristol-Myers Squibb (BMY) to Acquire Celgene Corp. (CELG) for Approx. $74B
-
158,042 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All